Citigroup Maintains Neutral on Core Laboratories, Lowers Price Target to $13

Benzinga · 05/13 19:03
Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Neutral and lowers the price target from $16 to $13.